NYSE · CIK 0001114483
ITGR Integer Holdings Corp
Insider trading from SEC Form 4. Last filing 26 d ago. Close $126.61 on Oct 9, 2026, +100% from the 52-week low and -0% from the high.
Last 90 days
Net insider value
-$5.2M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$5.2M by 2 insiders
Insiders on file
16
with a Form 4 at this company
Price and insider trades, last year
ITGROct 9, 2026 · close 126.61
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Integer Holdings Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | Kirk K Thor Chief Human Resources Officer sell | $4.0M 31,540 shares | -82% | - | |
| 73Notable | Andrew Senn President, Growth & Innovation sell | $1.2M 9,408 shares | -64% | - | |
| 28Weak | Tommy P Thomas VP, Corporate Controller sell | $70k 825 shares | -16% | +31% from low-35% from high | |
| 64Notable | John A Harris EVP, Global Ops and Manufactur buy | $116k 1,650 shares | +37% | +10% from low-52% from high | |
| 27Weak | Tommy P Thomas VP, Corporate Controller sell | $62k 884 shares | -20% | +10% from low-52% from high | |
| 61Notable | Cheryl C Capps director buy | $107k 1,600 shares | +16% | +5% from low-54% from high | |
| 66Notable | Diron Smith EVP, Chief Financial Officer buy | $75k 1,116 shares | +17% | +8% from low-53% from high | |
| 73Notable | Payman Khales President & CEO buy | $203k 3,127 shares | +16% | 0% from low-56% from high | |
| 43Moderate | Donald J Spence director sell | $1.8M 14,739 shares | -44% | +13% from low-17% from high | |
| 43Moderate | Martin C Maxwell director sell | $1.1M 8,720 shares | -28% | +13% from low-16% from high | |
| 55Moderate | Joseph W Dziedzic President & CEO sell | $42M 338,975 shares | -88% | +18% from low-13% from high |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Kirk K Thor Chief Human Resources Officer | SOpen-market sale Common Stock | -19,773 | $126.25 | $2.5M | 18,920 | 26 d ago |
| Sep 15, 2026 | Kirk K Thor Chief Human Resources Officer | SOpen-market sale Common Stock | -11,767 | $126.23 | $1.5M | 7,153 | 26 d ago |
| Sep 8, 2026 | Andrew Senn President, Growth & Innovation | SOpen-market sale Common Stock | -9,408 | $126.30 | $1.2M | 5,405 | 32 d ago |
| Mar 24, 2026 | Terence Carr EVP, Qlty & Regulatory Affairs | MOption exercise Common Stock | +1,350 | - | - | 1,350 | Mar 25, 2026 |
| Mar 24, 2026 | Lindsay K. Blackwood SVP, Gen Counsel & Secretary | MOption exercise Common Stock | +1,777 | - | - | 1,777 | Mar 25, 2026 |
| Mar 12, 2026 | James Francis Flanagan director | AGrant or award Common Stock | +410 | $0.00 | $0 | 410 | Mar 25, 2026 |
| Mar 12, 2026 | Aaron Kapito director | AGrant or award Common Stock | +410 | $0.00 | $0 | 1,371 | Mar 25, 2026 |
| Mar 24, 2026 | Terence Carr EVP, Qlty & Regulatory Affairs | FTax withholding Common Stock | -398 | $86.19 | $34k | 952 | Mar 25, 2026 |
| Mar 24, 2026 | Lindsay K. Blackwood SVP, Gen Counsel & Secretary | MOption exercise Common Stock | +1,706 | - | - | 3,483 | Mar 25, 2026 |
| Mar 24, 2026 | Terence Carr EVP, Qlty & Regulatory Affairs | MOption exercise Restricted Stock Unitsderivative | -1,350 | $0.00 | $0 | 2,702 | Mar 25, 2026 |
| Mar 24, 2026 | Lindsay K. Blackwood SVP, Gen Counsel & Secretary | FTax withholding Common Stock | -1,049 | $86.19 | $90k | 2,434 | Mar 25, 2026 |
| Mar 24, 2026 | Lindsay K. Blackwood SVP, Gen Counsel & Secretary | MOption exercise Restricted Stock Unitsderivative | -1,777 | $0.00 | $0 | 3,556 | Mar 25, 2026 |
| Mar 24, 2026 | Lindsay K. Blackwood SVP, Gen Counsel & Secretary | MOption exercise Restricted Stock Unitsderivative | -1,706 | $0.00 | $0 | 1,707 | Mar 25, 2026 |
| Mar 13, 2026 | Tommy P Thomas VP, Corporate Controller | SOpen-market sale Common Stock | -825 | $85.00 | $70k | 4,381 | Mar 17, 2026 |
| Feb 20, 2026 | Andrew Senn President, Cardio & Vascular | AGrant or award Common Stock | +2,340 | $0.00 | $0 | 13,880 | Feb 24, 2026 |
| Feb 20, 2026 | Jim Stephens President, CRM & Neuro | AGrant or award Common Stock | +2,691 | $0.00 | $0 | 5,024 | Feb 24, 2026 |
| Feb 20, 2026 | Diron Smith EVP, Chief Financial Officer | AGrant or award Common Stock | +798 | $0.00 | $0 | 10,936 | Feb 24, 2026 |
| Feb 20, 2026 | Kirk K Thor Chief Human Resources Officer | AGrant or award Common Stock | +4,475 | $0.00 | $0 | 32,630 | Feb 24, 2026 |
| Feb 20, 2026 | Tommy P Thomas VP, Corporate Controller | AGrant or award Common Stock | +923 | $0.00 | $0 | 4,980 | Feb 24, 2026 |
| Feb 20, 2026 | Payman Khales President & CEO | AGrant or award Common Stock | +7,389 | $0.00 | $0 | 32,861 | Feb 24, 2026 |
| Feb 20, 2026 | Jim Stephens President, CRM & Neuro | FTax withholding Common Stock | -656 | $84.85 | $56k | 4,368 | Feb 24, 2026 |
| Feb 20, 2026 | Kirk K Thor Chief Human Resources Officer | AGrant or award Common Stock | +4,550 | $0.00 | $0 | 37,180 | Feb 24, 2026 |
| Feb 20, 2026 | Tommy P Thomas VP, Corporate Controller | AGrant or award Common Stock | +939 | $0.00 | $0 | 5,919 | Feb 24, 2026 |
| Feb 20, 2026 | Diron Smith EVP, Chief Financial Officer | AGrant or award Common Stock | +817 | $0.00 | $0 | 11,753 | Feb 24, 2026 |
| Feb 20, 2026 | Payman Khales President & CEO | AGrant or award Common Stock | +7,516 | $0.00 | $0 | 40,377 | Feb 24, 2026 |
| Feb 20, 2026 | Andrew Senn President, Cardio & Vascular | AGrant or award Common Stock | +2,380 | $0.00 | $0 | 16,260 | Feb 24, 2026 |
| Feb 20, 2026 | Andrew Senn President, Cardio & Vascular | FTax withholding Common Stock | -1,447 | $84.85 | $123k | 14,813 | Feb 24, 2026 |
| Feb 20, 2026 | Diron Smith EVP, Chief Financial Officer | FTax withholding Common Stock | -394 | $84.85 | $33k | 11,359 | Feb 24, 2026 |
| Feb 20, 2026 | Tommy P Thomas VP, Corporate Controller | FTax withholding Common Stock | -713 | $84.85 | $60k | 5,206 | Feb 24, 2026 |
| Feb 20, 2026 | Payman Khales President & CEO | FTax withholding Common Stock | -4,638 | $84.85 | $394k | 35,739 | Feb 24, 2026 |
| Feb 20, 2026 | Kirk K Thor Chief Human Resources Officer | FTax withholding Common Stock | -2,198 | $84.85 | $187k | 34,982 | Feb 24, 2026 |
| Feb 24, 2026 | Payman Khales President & CEO | MOption exercise Common Stock | +16,077 | - | - | 51,816 | Feb 24, 2026 |
| Feb 24, 2026 | Payman Khales President & CEO | MOption exercise Common Stock | +26,983 | - | - | 78,799 | Feb 24, 2026 |
| Feb 24, 2026 | Payman Khales President & CEO | FTax withholding Common Stock | -16,945 | $87.10 | $1.5M | 61,854 | Feb 24, 2026 |
| Feb 24, 2026 | Payman Khales President & CEO | MOption exercise Restricted Stock Unitsderivative | -16,077 | $0.00 | $0 | 0 | Feb 24, 2026 |
| Feb 24, 2026 | Payman Khales President & CEO | MOption exercise Restricted Stock Unitsderivative | -26,983 | $0.00 | $0 | 0 | Feb 24, 2026 |
| Jan 17, 2026 | John A Harris EVP, Global Ops and Manufactur | MOption exercise Common Stock | +512 | - | - | 6,578 | Jan 21, 2026 |
| Jan 17, 2026 | Kirk K Thor Chief Human Resources Officer | MOption exercise Common Stock | +551 | - | - | 27,240 | Jan 21, 2026 |
| Jan 17, 2026 | Tommy P Thomas VP, Corporate Controller | MOption exercise Common Stock | +218 | - | - | 3,814 | Jan 21, 2026 |
| Jan 19, 2026 | Jim Stephens President, CRM & Neuro | MOption exercise Common Stock | +758 | - | - | 2,032 | Jan 21, 2026 |
| Jan 17, 2026 | Payman Khales President & CEO | MOption exercise Common Stock | +1,260 | - | - | 24,125 | Jan 21, 2026 |
| Jan 17, 2026 | Diron Smith EVP, Chief Financial Officer | MOption exercise Common Stock | +1,359 | - | - | 9,057 | Jan 21, 2026 |
| Jan 16, 2026 | Terence Carr EVP, Qlty & Regulatory Affairs | AGrant or award Restricted Stock Unitsderivative | +1,554 | $0.00 | $0 | 1,554 | Jan 21, 2026 |
| Jan 17, 2026 | Andrew Senn SVP, Strategy and Business Dev | MOption exercise Common Stock | +630 | - | - | 10,038 | Jan 21, 2026 |
| Jan 16, 2026 | Lindsay K. Blackwood SVP, Gen Counsel & Secretary | AGrant or award Restricted Stock Unitsderivative | +2,720 | $0.00 | $0 | 2,720 | Jan 21, 2026 |
| Jan 19, 2026 | Andrew Senn SVP, Strategy and Business Dev | MOption exercise Common Stock | +363 | - | - | 10,401 | Jan 21, 2026 |
| Jan 19, 2026 | Diron Smith EVP, Chief Financial Officer | MOption exercise Common Stock | +1,709 | - | - | 10,766 | Jan 21, 2026 |
| Jan 17, 2026 | Jim Stephens President, CRM & Neuro | MOption exercise Common Stock | +748 | - | - | 2,780 | Jan 21, 2026 |
| Jan 19, 2026 | John A Harris EVP, Global Ops and Manufactur | MOption exercise Common Stock | +636 | - | - | 7,214 | Jan 21, 2026 |
| Jan 19, 2026 | Kirk K Thor Chief Human Resources Officer | MOption exercise Common Stock | +694 | - | - | 27,934 | Jan 21, 2026 |
| Jan 19, 2026 | Tommy P Thomas VP, Corporate Controller | MOption exercise Common Stock | +240 | - | - | 4,054 | Jan 21, 2026 |
| Jan 19, 2026 | Payman Khales President & CEO | MOption exercise Common Stock | +961 | - | - | 25,086 | Jan 21, 2026 |
| Jan 20, 2026 | Andrew Senn SVP, Strategy and Business Dev | MOption exercise Common Stock | +2,224 | - | - | 12,625 | Jan 21, 2026 |
| Jan 19, 2026 | Jim Stephens President, CRM & Neuro | FTax withholding Common Stock | -447 | $85.78 | $38k | 2,333 | Jan 21, 2026 |
| Jan 20, 2026 | Kirk K Thor Chief Human Resources Officer | MOption exercise Common Stock | +816 | - | - | 28,750 | Jan 21, 2026 |
| Jan 20, 2026 | Tommy P Thomas VP, Corporate Controller | MOption exercise Common Stock | +337 | - | - | 4,391 | Jan 21, 2026 |
| Jan 20, 2026 | Payman Khales President & CEO | MOption exercise Common Stock | +1,348 | - | - | 26,434 | Jan 21, 2026 |
| Jan 20, 2026 | Diron Smith EVP, Chief Financial Officer | MOption exercise Common Stock | +292 | - | - | 11,058 | Jan 21, 2026 |
| Jan 19, 2026 | John A Harris EVP, Global Ops and Manufactur | FTax withholding Common Stock | -552 | $85.78 | $47k | 6,662 | Jan 21, 2026 |
| Jan 19, 2026 | Andrew Senn SVP, Strategy and Business Dev | FTax withholding Common Stock | -361 | $85.78 | $31k | 12,264 | Jan 21, 2026 |
| Jan 19, 2026 | Diron Smith EVP, Chief Financial Officer | FTax withholding Common Stock | -848 | $85.78 | $73k | 10,210 | Jan 21, 2026 |
| Jan 16, 2026 | John A Harris EVP, Global Ops and Manufactur | AGrant or award Restricted Stock Unitsderivative | +2,720 | $0.00 | $0 | 2,720 | Jan 21, 2026 |
| Jan 16, 2026 | Jim Stephens President, CRM & Neuro | AGrant or award Restricted Stock Unitsderivative | +3,885 | $0.00 | $0 | 3,885 | Jan 21, 2026 |
| Jan 19, 2026 | Kirk K Thor Chief Human Resources Officer | FTax withholding Common Stock | -370 | $85.78 | $32k | 28,380 | Jan 21, 2026 |
| Jan 19, 2026 | Tommy P Thomas VP, Corporate Controller | FTax withholding Common Stock | -193 | $85.78 | $17k | 4,198 | Jan 21, 2026 |
| Jan 19, 2026 | Payman Khales President & CEO | FTax withholding Common Stock | -633 | $85.78 | $54k | 25,801 | Jan 21, 2026 |
| Jan 19, 2026 | Jim Stephens President, CRM & Neuro | MOption exercise Restricted Stock Unitsderivative | -758 | $0.00 | $0 | 759 | Jan 21, 2026 |
| Jan 20, 2026 | Kirk K Thor Chief Human Resources Officer | FTax withholding Common Stock | -225 | $85.15 | $19k | 28,155 | Jan 21, 2026 |
| Jan 20, 2026 | Tommy P Thomas VP, Corporate Controller | FTax withholding Common Stock | -141 | $85.15 | $12k | 4,057 | Jan 21, 2026 |
| Jan 20, 2026 | Payman Khales President & CEO | FTax withholding Common Stock | -329 | $85.15 | $28k | 25,472 | Jan 21, 2026 |
| Jan 16, 2026 | John A Harris EVP, Global Ops and Manufactur | AGrant or award Restricted Stock Unitsderivative | +5,440 | $0.00 | $0 | 5,440 | Jan 21, 2026 |
| Jan 20, 2026 | Andrew Senn SVP, Strategy and Business Dev | FTax withholding Common Stock | -724 | $85.15 | $62k | 11,540 | Jan 21, 2026 |
| Jan 20, 2026 | Diron Smith EVP, Chief Financial Officer | FTax withholding Common Stock | -72 | $85.15 | $6,131 | 10,138 | Jan 21, 2026 |
| Jan 17, 2026 | John A Harris EVP, Global Ops and Manufactur | MOption exercise Restricted Stock Unitsderivative | -512 | $0.00 | $0 | 1,024 | Jan 21, 2026 |
| Jan 17, 2026 | Jim Stephens President, CRM & Neuro | MOption exercise Restricted Stock Unitsderivative | -748 | $0.00 | $0 | 1,497 | Jan 21, 2026 |
| Jan 16, 2026 | Kirk K Thor Chief Human Resources Officer | AGrant or award Restricted Stock Unitsderivative | +6,120 | $0.00 | $0 | 6,120 | Jan 21, 2026 |
| Jan 16, 2026 | Payman Khales President & CEO | AGrant or award Restricted Stock Unitsderivative | +19,429 | $0.00 | $0 | 19,429 | Jan 21, 2026 |
| Jan 16, 2026 | Andrew Senn SVP, Strategy and Business Dev | AGrant or award Restricted Stock Unitsderivative | +3,497 | $0.00 | $0 | 3,497 | Jan 21, 2026 |
| Jan 16, 2026 | Diron Smith EVP, Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +7,091 | $0.00 | $0 | 7,091 | Jan 21, 2026 |
| Jan 16, 2026 | Tommy P Thomas VP, Corporate Controller | AGrant or award Restricted Stock Unitsderivative | +1,049 | $0.00 | $0 | 1,049 | Jan 21, 2026 |
| Jan 17, 2026 | Kirk K Thor Chief Human Resources Officer | MOption exercise Restricted Stock Unitsderivative | -551 | $0.00 | $0 | 1,103 | Jan 21, 2026 |
| Jan 17, 2026 | Tommy P Thomas VP, Corporate Controller | MOption exercise Restricted Stock Unitsderivative | -218 | $0.00 | $0 | 438 | Jan 21, 2026 |
| Jan 17, 2026 | Payman Khales President & CEO | MOption exercise Restricted Stock Unitsderivative | -1,260 | $0.00 | $0 | 2,522 | Jan 21, 2026 |
| Jan 17, 2026 | Andrew Senn SVP, Strategy and Business Dev | MOption exercise Restricted Stock Unitsderivative | -630 | $0.00 | $0 | 1,261 | Jan 21, 2026 |
| Jan 17, 2026 | Diron Smith EVP, Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,359 | $0.00 | $0 | 2,719 | Jan 21, 2026 |
| Jan 19, 2026 | John A Harris EVP, Global Ops and Manufactur | MOption exercise Restricted Stock Unitsderivative | -636 | $0.00 | $0 | 636 | Jan 21, 2026 |
| Jan 19, 2026 | Andrew Senn SVP, Strategy and Business Dev | MOption exercise Restricted Stock Unitsderivative | -363 | $0.00 | $0 | 363 | Jan 21, 2026 |
| Jan 19, 2026 | Diron Smith EVP, Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,709 | $0.00 | $0 | 1,710 | Jan 21, 2026 |
| Jan 19, 2026 | Kirk K Thor Chief Human Resources Officer | MOption exercise Restricted Stock Unitsderivative | -694 | $0.00 | $0 | 695 | Jan 21, 2026 |
| Jan 19, 2026 | Tommy P Thomas VP, Corporate Controller | MOption exercise Restricted Stock Unitsderivative | -240 | $0.00 | $0 | 241 | Jan 21, 2026 |
| Jan 19, 2026 | Payman Khales President & CEO | MOption exercise Restricted Stock Unitsderivative | -961 | $0.00 | $0 | 962 | Jan 21, 2026 |
| Jan 20, 2026 | Kirk K Thor Chief Human Resources Officer | MOption exercise Restricted Stock Unitsderivative | -816 | $0.00 | $0 | 0 | Jan 21, 2026 |
| Jan 20, 2026 | Tommy P Thomas VP, Corporate Controller | MOption exercise Restricted Stock Unitsderivative | -337 | $0.00 | $0 | 0 | Jan 21, 2026 |
| Jan 20, 2026 | Payman Khales President & CEO | MOption exercise Restricted Stock Unitsderivative | -1,348 | $0.00 | $0 | 0 | Jan 21, 2026 |
| Jan 20, 2026 | Andrew Senn SVP, Strategy and Business Dev | MOption exercise Restricted Stock Unitsderivative | -2,224 | $0.00 | $0 | 0 | Jan 21, 2026 |
| Jan 20, 2026 | Diron Smith EVP, Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -292 | $0.00 | $0 | 0 | Jan 21, 2026 |
| Jan 2, 2026 | Pamela G Bailey director | MOption exercise Common Stock | +2,883 | $48.43 | $140k | 56,052 | Jan 5, 2026 |
| Jan 2, 2026 | Pamela G Bailey director | FTax withholding Common Stock | -1,799 | $77.63 | $140k | 54,253 | Jan 5, 2026 |
| Jan 2, 2026 | Pamela G Bailey director | MOption exercise Stock Optionsderivative | -2,883 | $0.00 | $0 | 0 | Jan 5, 2026 |
| Dec 12, 2025 | Martin C Maxwell director | MOption exercise Common Stock | +2,883 | $48.43 | $140k | 25,053 | Dec 16, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Pamela G Baileydirector
- Lindsay K. BlackwoodSVP, Gen Counsel & Secretary
- Cheryl C Cappsdirector
- Terence CarrEVP, Qlty & Regulatory Affairs
- Joseph W DziedzicPresident & CEO
- James Francis Flanagandirector
- John A HarrisEVP, Global Ops and Manufactur
- Aaron Kapitodirector
- Payman KhalesPresident & CEO
- Martin C Maxwelldirector
- Andrew SennPresident, Cardio & Vascular
- Diron SmithEVP, Chief Financial Officer
- Donald J Spencedirector
- Jim StephensPresident, CRM & Neuro
- Tommy P ThomasVP, Corporate Controller
- Kirk K ThorChief Human Resources Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.